Biolidics Ltd
SGX:8YY
Biolidics Ltd
Research & Development
Biolidics Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biolidics Ltd
SGX:8YY
|
Research & Development
-S$1k
|
CAGR 3-Years
90%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
|
|
Vicplas International Ltd
SGX:569
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Q
|
Quantum Healthcare Ltd
SGX:V8Y
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biolidics Ltd
Glance View
Biolidics Ltd. operates as a medical technology company. The firm is primarily engaged in the research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics-related industrial design services and investment holdings. The company segments include cancer, infectious diseases and laboratory services. The cancer segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the cancer field. The infectious diseases segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the infectious diseases field. The laboratory services segment involves the business, operation and provision of laboratory services to customers.
See Also
What is Biolidics Ltd's Research & Development?
Research & Development
-1k
SGD
Based on the financial report for Dec 31, 2024, Biolidics Ltd's Research & Development amounts to -1k SGD.
What is Biolidics Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
76%
Over the last year, the Research & Development growth was 97%. The average annual Research & Development growth rates for Biolidics Ltd have been 90% over the past three years , 76% over the past five years .
